Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Prostatic Neoplasms 3Recurrence 1Rectal Neoplasms 1Neuroendocrine Tumors 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Leukemia, Myeloid, Acute 1Leukemia, Erythroblastic, Acute 1Hodgkin Disease 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Oxaliplatin 271Fluorouracil 268Capecitabine 234Leucovorin 209Irinotecan 152Radiotherapy 138Bevacizumab 114Cetuximab 82Surgical Procedures, Operative 51Folfox protocol 48Neoadjuvant Therapy 45Drug Therapy 43Radiation 42Chemotherapy, Adjuvant 34Chemoradiotherapy 34Panitumumab 27Magnetic Resonance Spectroscopy 26XELOX 25Radiotherapy, Intensity-Modulated 23Biopsy 20Surveys and Questionnaires 18Laparoscopy 18Proctectomy 17Floxuridine 17Early Intervention, Educational 16Nivolumab 15Immunohistochemistry 15Gene Expression Profiling 15Gemcitabine 15pembrolizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Salvage Therapy × Clear all
NCT06143605 2023-11-22

Clinical Relevance of the Salvage Treatment for Colorectal Neuroendocrine Tumors

Sun Yat-sen University

Completed
527 enrolled
EndocrineGastrointestinalNET

Rectal Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡